nm23-H1 protein expression in anal canal carcinoma: Does it correlate with prognosis?

Journal of Surgical Oncology

Volumn 74, Issue 2, 2000, Pages 163-166

  Indinnimeo, Marileda ^a   Cicchini, Claudia ^a   Stazi, Alessandro ^a   Giarnieri, Enrico ^a   Limiti, Maria Rosaria ^a   Ghini, Christian ^a   Vecchione, Aldo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anal neoplasms; Immunohistochemistry; Monoclonal antibody; nm23; Prognosis

Indexed keywords

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER SURVIVAL; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MITOMYCIN; MONOMERIC GTP-BINDING PROTEINS; NUCLEOSIDE-DIPHOSPHATE KINASE; PROGNOSIS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 0033948385     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200006)74:2<163::AID-JSO16>3.0.CO;2-D     Document Type: Article

References (26)

1. MacDonald NJ, De La Rosa A, Steeg PS: The potential roles of nm23 in cancer metastasis and cellular differentiation. Eur J Cancer 1995;31A:1096-1110.
2. Steeg PS, Bevilacqua G, Kopper L, et al.: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-204.
3. Leone A, Flatow U, King CR, et al.: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991;65:25-35.
4. Stahl JA, Leone A, Rosengard AM, et al.: Identification of a second nm23 gene, nm23-H2. Cancer Res 1991;51:445-449.
5. Martinez R, Venturelli D, Perrotti D, et al.: Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family. Cancer Res 1997;57: 1180-1187.
6. MacDonald NJ, De La Rosa A, Benedict MA, et al.: A novel phosphorylation of nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastasis. J Biol Chem 1993;269:25780-25789.
7. Kantor JD, McCormick B, Steeg PS, et al.: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993;53:1971-1973.
8. Ura H, Denno R, Hirata K.: Correlation between nm23 protein and several cell adhesion molecules in human gastric carcinoma. Jpn J Cancer Res 1996;87:512-517.
9. Nakayama T, Ohtsuru A, Nakao K, et al.: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 1992;84: 1349-1354.
10. Boix L, Bruix J, Campo E, et al.: Nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 1994;107:486-491.
11. Yamaguchi A, Urano T, Goi T, et al.: Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 1994;73:2280-2284.
12. Tokunaga Y, Urano T, Furukawa K, et al.: Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer, Int J Cancer 1993;55:66-71.
13. Kodera Y, Isobe K, Yamauchi M, et al.: Expression of nm23-H1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis. Cancer 1994;73:259-265.
14. Caligo MA, Grammatico P, Cipollini G, et al.: A low NM23.H1 gene expression identifying high malignancy human melanomas. Melanoma Res 1994;4:179-184.
15. Xerri L, Grob JJ, Battyani Z, et al.: NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer 1994;70:1224-1228.
16. Ogawa I, Takata T, Miyauchi M, et al.: nm23-H1 expression in salivary adenoid cystic carcinoma in relation to metastasis and survival. Oncol Rep 1997;4:707-711.
17. Campo E, Miquel R, Jares P, et al.: Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer 1994;73:2913-2921.
18. Tannapfel A, Kockerling F, Katalinic A, Wittekind C.: Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum 1995;38:651-654.
19. Heys SD, Langlois N, Smith IC, et al.: NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer. Oncol Rep 1998;5:735-739.
20. Lindmark G.: NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer. Br J Cancer 1996;74:1413-1418.
21. Giarnieri E, Alderisio M, Valli C, Vecchione A, et al.: Overexpression of NDPKinase nm23 associated with ploidy image analysis in colorectal cancer. Anticancer Res 1995;15:2049-2054.
22. Hailat N, Keim DR, Melhem RF, et al.: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and N-myc gene amplification. J Clin Invest 1991;88:341-345.
23. Leone A, Seeger RC, Hong CM, et al.: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993;8:855-865.
24. Higashiyama M, Doi O, Yokouchi H, et al.: Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br J Cancer 1992; 66:533-536.
25. Luo W, Matsuo K, Nagayama Y, et al.: Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis. Thyroid 1993;3:105-109.
26. Ayhan A, Usubutun A, Ozen H, et al.: nm23 protein expression in renal cell tumors: the role of the cell type. Oncol Rep 1998;5: 979-983.